Form 4: NeueHealth CFO Jay Matushak Reports Stock Transactions
SEC Form 4 Filing
Jay Matushak, CFO of NeueHealth, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On October 4, 2024, Jay Matushak, CFO of NeueHealth, vested 263 restricted stock units, each representing one share of NeueHealth's common stock.
- Following the vesting, Mr. Matushak sold 87 shares of common stock on October 7, 2024, at a price of $5.18 per share.
- The sale was to cover tax withholding obligations related to the vesting of the restricted stock units and was not a discretionary transaction.
- After these transactions, Mr. Matushak beneficially owns 9,480 shares of NeueHealth common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US financial market, providing transparency into the transactions of company insiders. This filing indicates the CFO's transactions related to vested stock units and tax obligations.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| October 4, 2022 | One-third of the original grant amount of restricted stock units vested. |
| October 4, 2023 | One-third of the original grant amount of restricted stock units vested. |
| October 4, 2024 | Restricted stock units vested; 263 shares acquired. |
| October 7, 2024 | 87 shares sold at $5.18 per share. |
| October 8, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.